TrialBlood cancer journal2014

Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.

T Mino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.